These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 20416090)

  • 1. Azithromycin effectiveness against intracellular infections of Francisella.
    Ahmad S; Hunter L; Qin A; Mann BJ; van Hoek ML
    BMC Microbiol; 2010 Apr; 10():123. PubMed ID: 20416090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardized broth microdilution antimicrobial susceptibility testing of Francisella tularensis subsp. holarctica strains from Europe and rare Francisella species.
    Georgi E; Schacht E; Scholz HC; Splettstoesser WD
    J Antimicrob Chemother; 2012 Oct; 67(10):2429-33. PubMed ID: 22763567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Francisella tularensis subsp. tularensis Schu S4 disulfide bond formation protein B, but not an RND-type efflux pump, is required for virulence.
    Qin A; Scott DW; Mann BJ
    Infect Immun; 2008 Jul; 76(7):3086-92. PubMed ID: 18458069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of TolC Orthologs to
    Kopping EJ; Doyle CR; Sampath V; Thanassi DG
    Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670554
    [No Abstract]   [Full Text] [Related]  

  • 5. Macrophages Demonstrate Guanylate-Binding Protein-Dependent and Bacterial Strain-Dependent Responses to
    Mohammadi N; Lindgren H; Yamamoto M; Martin A; Henry T; Sjöstedt A
    Front Cell Infect Microbiol; 2021; 11():784101. PubMed ID: 35004352
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates.
    Santiago AE; Mann BJ; Qin A; Cunningham AL; Cole LE; Grassel C; Vogel SN; Levine MM; Barry EM
    Pathog Dis; 2015 Aug; 73(6):ftv036. PubMed ID: 25986219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of Francisella tularensis with Alveolar Type II Epithelial Cells and the Murine Respiratory Epithelium.
    Faron M; Fletcher JR; Rasmussen JA; Apicella MA; Jones BD
    PLoS One; 2015; 10(5):e0127458. PubMed ID: 26010977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic diversity within the genus Francisella as revealed by comparative analyses of the genomes of two North American isolates from environmental sources.
    Siddaramappa S; Challacombe JF; Petersen JM; Pillai S; Kuske CR
    BMC Genomics; 2012 Aug; 13():422. PubMed ID: 22920915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Francisella philomiragia Infection and Lethality in Mammalian Tissue Culture Cell Models, Galleria mellonella, and BALB/c Mice.
    Propst CN; Pylypko SL; Blower RJ; Ahmad S; Mansoor M; van Hoek ML
    Front Microbiol; 2016; 7():696. PubMed ID: 27252681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of Francisella tularensis Intracellular Growth by Pulmonary Epithelial Cells.
    Maggio S; Takeda K; Stark F; Meierovics AI; Yabe I; Cowley SC
    PLoS One; 2015; 10(9):e0138565. PubMed ID: 26379269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Survival of Virulent Tularemia Pathogens outside a Host in Conditions That Mimic Natural Aquatic Environments.
    Golovliov I; Bäckman S; Granberg M; Salomonsson E; Lundmark E; Näslund J; Busch JD; Birdsell D; Sahl JW; Wagner DM; Johansson A; Forsman M; Thelaus J
    Appl Environ Microbiol; 2021 Feb; 87(6):. PubMed ID: 33397692
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential Substrate Usage and Metabolic Fluxes in
    Chen F; Rydzewski K; Kutzner E; Häuslein I; Schunder E; Wang X; Meighen-Berger K; Grunow R; Eisenreich W; Heuner K
    Front Cell Infect Microbiol; 2017; 7():275. PubMed ID: 28680859
    [No Abstract]   [Full Text] [Related]  

  • 13. Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease.
    Hollis DG; Weaver RE; Steigerwalt AG; Wenger JD; Moss CW; Brenner DJ
    J Clin Microbiol; 1989 Jul; 27(7):1601-8. PubMed ID: 2671019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis.
    Kieffer TL; Cowley S; Nano FE; Elkins KL
    Microbes Infect; 2003 Apr; 5(5):397-403. PubMed ID: 12737995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge.
    Pechous RD; McCarthy TR; Mohapatra NP; Soni S; Penoske RM; Salzman NH; Frank DW; Gunn JS; Zahrt TC
    PLoS One; 2008 Jun; 3(6):e2487. PubMed ID: 18575611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bis-indolic compounds as potential new therapeutic alternatives for tularaemia.
    Caspar Y; Sutera V; Boisset S; Denis JN; Maurin M
    Front Cell Infect Microbiol; 2014; 4():24. PubMed ID: 24579066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of Francisella novicida that alter the mechanism of its phagocytosis by murine macrophages.
    Lai XH; Shirley RL; Crosa L; Kanistanon D; Tempel R; Ernst RK; Gallagher LA; Manoil C; Heffron F
    PLoS One; 2010 Jul; 5(7):e11857. PubMed ID: 20686600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge.
    Cong Y; Yu JJ; Guentzel MN; Berton MT; Seshu J; Klose KE; Arulanandam BP
    Vaccine; 2009 Sep; 27(41):5554-61. PubMed ID: 19651173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acid phosphatase AcpA is secreted in vitro and in macrophages by Francisella spp.
    Dai S; Mohapatra NP; Schlesinger LS; Gunn JS
    Infect Immun; 2012 Mar; 80(3):1088-97. PubMed ID: 22184418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
    Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.